Medical use of prescription stimulants for ADHD increased between 2005 and 2023, but nonmedical use decreased over that time.

Black patients with acral lentiginous melanoma are at a higher risk of mortality than White patients, independent of known risk factors.

Patients with moderate to severe and severe alopecia areata have a greater burden of comorbid atopic dermatitis than those with mild alopecia areata.

Some of the notable drug approvals that occurred in July 2025.